Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44

Wedbush analyst Laura Chico has initiated coverage on Korsana Biosciences (NASDAQ: KRSA) with an Outperform rating. The firm has set a price target of $44 for the company's stock.